How to Buy Cardio Diagnostics Holdings Stock
Cardio Diagnostics Holdings Inc
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc.
Cardio Diagnostics Holdings stock last closed at $0.23, up 5.12% from the previous day, and has decreased 25.9% in one year. It has underperformed other stocks in the Biotechnology industry by 0.16 percentage points. Cardio Diagnostics Holdings stock is currently +32.16% from its 52-week low of $0.17, and -93.65% from its 52-week high of $3.56.
At the moment, there are 23.94M CDIO shares outstanding. The market value of CDIO is $5.41M. In the past 24 hours, 1.13M CDIO shares were traded.
How to Buy Cardio Diagnostics Holdings Stock
Wondering how to invest in Cardio Diagnostics Holdings stock? Here's how.
- Decide where to buy Cardio Diagnostics Holdings stock: You need to pick an online brokerage, but don't worry - we've researched dozens of online brokerages and apps to help you figure out where to buy Cardio Diagnostics Holdings stock.
- Sign up for your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Deposit money your investment account: Pick your method of payment and add your info.
- Evaluate Cardio Diagnostics Holdings stock: The Cardio Diagnostics Holdings ticker symbol is CDIO. Is Cardio Diagnostics Holdings stock a good investment? Should you buy shares of CDIO? How do CDIO's underlying business fundamentals look? Do top analysts think Cardio Diagnostics Holdings is a good buy? Why has CDIO's stock price moved recently? (Hint: Our stock research website can help you decide if CDIO is a good stock to buy).
- Execute your CDIO buy order: Decide if you will purchase CDIO shares at the current market price or use a limit order to purchase CDIO stock at a specific price.
- Get the latest news on your CDIO position: Create a watchlist to important updates regarding your new investment in Cardio Diagnostics Holdings shares.
Step 1: Decide where to buy Cardio Diagnostics Holdings stock
You need an online brokerage account in order to access the NASDAQ market and buy CDIO stock.
Our recommended brokerage: eToro
Based on our analysis, eToro is the best stock brokerage. eToro gives you:
- Invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to world markets: From Tech to Utilities, New York to London — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro boasts a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by signing up for an account with eToro today.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've chosen your brokerage, the next step is to fill out some personal information so you are able to buy CDIO today.
How to Create a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal info to start your new trading account.
- Send your details by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit money your investment account
Now that you have created your account on one of the best stock apps, your next step is to transfer the money for your investment:
Watch the video below for more details transferring funds into your brokerage account.
Step 4: Evaluate Cardio Diagnostics Holdings stock
After you have figured out the best place to buy Cardio Diagnostics Holdings stock, it's crucial to research their stock prior to buying, so you truly comprehend the risk and upside.
Cardio Diagnostics Holdings Numbers
CDIO Fundamentals
WallStreetZen was designed to help average investors perform more in-depth fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on CDIO's stock page.
What is the fair value of CDIO stock?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge CDIO's true value.
Using relative valuations measures:
- CDIO may be undervalued based on its P/B ratio of 1.76x, relative to Biotechnology industry P/B ratio of 5.96x
You can do additional valuation research on CDIO's stock here.
A look at CDIO Cashflows and Balance Sheet
Pros:
- CDIO has a low debt to equity ratio of 0.3.
- There are more short-term assets than short-term liabilities on the CDIO balance sheet.
- There are more short-term assets than long-term liabilities on the CDIO balance sheet.
Cons:
- CDIO has $1.32M in cash and short term investments. This is not sufficient to cover its annual cash burn of $5.91M.
- CDIO has cash burn of 5911251. It does not have enough cash and short-term investments to cover this.
- CDIO profit margin has gone up by 2,984.99 percentage points in the past year, but the company is still unprofitable.
Is CDIO stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 1 Wall Street analysts who give forecasts on CDIO, the consensus analyst rating on Cardio Diagnostics Holdings is a Buy
Please keep in mind that analyst forecasts are not stock recommendations, nor are they financial advice.
You can dive deeper into what analysts are forecasting on the Cardio Diagnostics Holdings stock forecast page.
CDIO Trading Indicators
CDIO Earnings
Last year, CDIO revenue was $39.14k. Over the last two year, CDIO's revenue has increased by 559.08% per year. This was faster than the Biotechnology industry average of 61.66%.
Dive into CDIO's earnings and revenue performance here.
Are CDIO insiders buying or selling the stock?
Over the last 12 months, insiders at CDIO have bought more shares than they have sold.
Meeshanthini Dogan, Chief Technology Officer of CDIO, was the latest CDIO insider to buy. They bought $19,999.85 worth of CDIO stock on Sep 6, 2024.
Get more info about who owns CDIO shares here.
Can I get consistent income from CDIO stock?
No, Cardio Diagnostics Holdings doesn't provide an income stream by paying out dividends.
CDIO Social Trading Data
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other investors have to say.
Step 5: Execute your CDIO buy order
You have two main options:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are usually fine for most investors. - Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
If you want to make sure you're buying or selling at a specific price, place a limit order.
Click the Open Trade button and eToro will place your order.
If you need additional info about buying stocks on eToro, click the helpful video below:
Step 6: Get the latest news on your CDIO position
Now that you own some CDIO stock, you'll want to keep up with your stock purchase.
Create a watchlist to track your CDIO stock.
CDIO Feed
How to Buy Stock in Cardio Diagnostics Holdings
To summarize, here are the 6 steps to buy Cardio Diagnostics Holdings stock:
- Decide where to buy Cardio Diagnostics Holdings stock
- Sign up for your brokerage account
- Deposit money your investment account
- Evaluate Cardio Diagnostics Holdings stock
- Execute your CDIO buy order
- Get the latest news on your CDIO position
If you are looking for a brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to keep an eye on your investment in Cardio Diagnostics Holdings, click below.
More Stock Buying Guides You Might Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.